BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33108958)

  • 1. Short-term oral administration of non-porous and mesoporous silica did not induce local or systemic toxicity in mice.
    Cabellos J; Gimeno-Benito I; Catalán J; Lindberg HK; Vales G; Fernandez-Rosas E; Ghemis R; Jensen KA; Atluri R; Vázquez-Campos S; Janer G
    Nanotoxicology; 2020 Dec; 14(10):1324-1341. PubMed ID: 33108958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary toxicity of synthetic amorphous silica - effects of porosity and copper oxide doping.
    Hadrup N; Aimonen K; Ilves M; Lindberg H; Atluri R; Sahlgren NM; Jacobsen NR; Barfod KK; Berthing T; Lawlor A; Norppa H; Wolff H; Jensen KA; Hougaard KS; Alenius H; Catalan J; Vogel U
    Nanotoxicology; 2021 Feb; 15(1):96-113. PubMed ID: 33176111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weak silica nanomaterial-induced genotoxicity can be explained by indirect DNA damage as shown by the OGG1-modified comet assay and genomic analysis.
    Pfuhler S; Downs TR; Allemang AJ; Shan Y; Crosby ME
    Mutagenesis; 2017 Jan; 32(1):5-12. PubMed ID: 27864332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silica nanoparticles as hepatotoxicants.
    Nishimori H; Kondoh M; Isoda K; Tsunoda S; Tsutsumi Y; Yagi K
    Eur J Pharm Biopharm; 2009 Aug; 72(3):496-501. PubMed ID: 19232391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice.
    Lee S; Kim MS; Lee D; Kwon TK; Khang D; Yun HS; Kim SH
    Int J Nanomedicine; 2013; 8():147-58. PubMed ID: 23326190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility.
    Mohammadpour R; Cheney DL; Grunberger JW; Yazdimamaghani M; Jedrzkiewicz J; Isaacson KJ; Dobrovolskaia MA; Ghandehari H
    J Control Release; 2020 Aug; 324():471-481. PubMed ID: 32464151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comet and micronucleus assays do not predict morphological transforming effects of silica particles in Syrian Hamster Embryo cells.
    Darne C; Coulais C; Terzetti F; Fontana C; Binet S; Gaté L; Guichard Y
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 796():23-33. PubMed ID: 26778506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic Oral Toxicity of Silica Nanoparticles and Silica Microparticles in Rats.
    Liang CL; Xiang Q; Cui WM; Fang J; Sun NN; Zhang XP; Li YN; Yang H; Yu Z; Jia XD
    Biomed Environ Sci; 2018 Mar; 31(3):197-207. PubMed ID: 29673442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of in vitro genotoxic, cytotoxic and transcriptomic responses following exposures to amorphous silica of different sizes.
    Decan N; Wu D; Williams A; Bernatchez S; Johnston M; Hill M; Halappanavar S
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 796():8-22. PubMed ID: 26778505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Oral Administration of Mesoporous Silica Nanoparticles Potentially Induced Colon Inflammation in Rats Through Alteration of Gut Microbiota.
    Yu Y; Wang Z; Wang R; Jin J; Zhu YZ
    Int J Nanomedicine; 2021; 16():881-893. PubMed ID: 33574668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
    Lin YS; Haynes CL
    J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape.
    Li L; Liu T; Fu C; Tan L; Meng X; Liu H
    Nanomedicine; 2015 Nov; 11(8):1915-24. PubMed ID: 26238077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity of amorphous silica particles with different structure and dimension in human and murine cell lines.
    Guidi P; Nigro M; Bernardeschi M; Scarcelli V; Lucchesi P; Onida B; Mortera R; Frenzilli G
    Mutagenesis; 2013 Mar; 28(2):171-80. PubMed ID: 23325795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution and excretion kinetics of orally administered silica nanoparticles in rats.
    Lee JA; Kim MK; Paek HJ; Kim YR; Kim MK; Lee JK; Jeong J; Choi SJ
    Int J Nanomedicine; 2014; 9 Suppl 2(Suppl 2):251-60. PubMed ID: 25565843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo toxicologic study of larger silica nanoparticles in mice.
    Chan WT; Liu CC; Chiang Chiau JS; Tsai ST; Liang CK; Cheng ML; Lee HC; Yeung CY; Hou SY
    Int J Nanomedicine; 2017; 12():3421-3432. PubMed ID: 28496319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute toxicity of intravenously administered titanium dioxide nanoparticles in mice.
    Xu J; Shi H; Ruth M; Yu H; Lazar L; Zou B; Yang C; Wu A; Zhao J
    PLoS One; 2013; 8(8):e70618. PubMed ID: 23950972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice.
    Liu T; Li L; Teng X; Huang X; Liu H; Chen D; Ren J; He J; Tang F
    Biomaterials; 2011 Feb; 32(6):1657-68. PubMed ID: 21093905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic toxicity of silica nanoparticles as a function of size and porosity.
    Mohammadpour R; Yazdimamaghani M; Cheney DL; Jedrzkiewicz J; Ghandehari H
    J Control Release; 2019 Jun; 304():216-232. PubMed ID: 31047961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles.
    Sayes CM; Reed KL; Glover KP; Swain KA; Ostraat ML; Donner EM; Warheit DB
    Inhal Toxicol; 2010 Mar; 22(4):348-54. PubMed ID: 20001567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity of synthetic amorphous silica nanoparticles in rats following short-term exposure. Part 1: oral route.
    Tarantini A; Huet S; Jarry G; Lanceleur R; Poul M; Tavares A; Vital N; Louro H; João Silva M; Fessard V
    Environ Mol Mutagen; 2015 Mar; 56(2):218-27. PubMed ID: 25504566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.